Perspectives on investigational drugs and immunotherapies for glioblastoma

Expert Opin Investig Drugs. 2016 Sep;25(9):1007-9. doi: 10.1080/13543784.2016.1213242.
No abstract available

Keywords: Glioblastoma; IDH; immune checkpoint inhibition; immunotherapy; vaccination.

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Cancer Vaccines / administration & dosage
  • Cancer Vaccines / immunology
  • Cancer Vaccines / therapeutic use*
  • Clinical Trials as Topic
  • Drugs, Investigational / administration & dosage
  • Drugs, Investigational / therapeutic use*
  • Glioblastoma / drug therapy*
  • Glioblastoma / genetics
  • Glioblastoma / immunology
  • Humans
  • Immunotherapy / methods*
  • Isocitrate Dehydrogenase / antagonists & inhibitors
  • Isocitrate Dehydrogenase / genetics
  • Mutation

Substances

  • Antineoplastic Agents
  • Cancer Vaccines
  • Drugs, Investigational
  • IDH2 protein, human
  • Isocitrate Dehydrogenase
  • IDH1 protein, human